Industry Applications
Medical-Grade Elastomers: Silicone, Butyl Rubber & Polyurethane in Medical Device Engineering
Technical guide to medical-grade elastomer selection under USP Class VI and ISO 10993 biocompatibility frameworks. Comparative analysis of silicone, butyl rubber (IIR/BIIR/CIIR), and thermoplastic polyurethane for implants, pharmaceutical closures, catheters, and seals.
Article Info
- Category
- Industry Applications
- Tags
- Medical-Grade RubberSilicone Medical DevicesBiocompatibilityPharmaceutical ClosuresMedical Catheters
- Keywords
- medical silicone / USP Class VI / ISO 10993 / butyl rubber stopper / medical elastomers / Nanjing Yuhang Rubber
Expertise Signal
- Technical review
- YuHang Rubber Technical Team
- Review Role
- Industrial Rubber Product Technical Review
- Known For
- Rubber FenderRubber TrackRubber SheetRubber HoseRubber ExtrusionCustom Rubber Parts
Industrial rubber product manufacturer covering rubber fenders, rubber tracks, rubber sheets, rubber hoses, extrusions, belts and custom molded rubber parts.
Medical-Grade Elastomers: Silicone, Butyl Rubber & Polyurethane in Medical Device Engineering
Published: 2026-05-12 | Reading time: 8 minutes
Introduction
Few engineering decisions carry stakes as high as material selection for medical devices. An O-ring in a pacemaker must maintain its sealing integrity for decades inside the human body. A pharmaceutical vial stopper must resist chemical interaction with a biologic formulation worth thousands of dollars per dose. A hemodialysis blood line must withstand repeated sterilization cycles without leaching plasticizers into the bloodstream.
Elastomers sit at the center of all these challenges. Three material families dominate medical elastomer applications: silicone rubber, prized for its unmatched biocompatibility; butyl rubber (IIR) and its halogenated derivatives, the industry standard for pharmaceutical packaging; and thermoplastic polyurethane (TPU), offering a tunable stiffness range for catheter applications. Selecting among them requires navigating a dense regulatory landscape -- primarily USP Class VI and the ISO 10993 series -- while balancing mechanical performance, sterilization compatibility, and cost.
This article provides a technically grounded comparison of these three material families, including sterilization compatibility data, regulatory test requirements, and a decision framework engineers can apply directly to device design.
The Regulatory Framework: More Than a Checklist
Two principal frameworks govern medical elastomer evaluation. Understanding their logic -- not just their requirements -- is essential for material selection.
USP Class VI: The North American Baseline
United States Pharmacopeia Chapter <88> establishes six biological reactivity classes (I through VI). Class VI represents the most stringent tier, required for materials intended for long-term implantation or indirect blood contact. The classification is determined by the battery of biological tests applied, not by a pass/fail on a single metric:
| Test | Class I-II | Class III-IV | Class V-VI | Duration |
|---|---|---|---|---|
| Systemic injection (mouse) | -- | Required | Required | 72 h observation |
| Intracutaneous reactivity (rabbit) | -- | Required | Required | 72 h observation |
| Implantation (rabbit muscle) | -- | -- | Required | 7+ days |
| Extraction media required | 1 (saline) | 2 (saline + ethanol) | 3 (saline + ethanol + PEG400) | -- |
The three-extractant requirement for Class VI is significant. Sodium chloride injection extracts water-soluble compounds; alcohol in saline extracts non-polar organics; polyethylene glycol 400 extracts lipophilic substances. A material that passes saline-only testing may still fail on PEG400 extraction, which leaches plasticizers, processing aids, and low-molecular-weight oligomers that aqueous extraction misses entirely.
Critically, USP Class VI alone is inadequate for full regulatory submission. The FDA expects Class VI data to be supplemented by the complete ISO 10993 evaluation. Class VI is the entry ticket, not the destination.
ISO 10993: The Global Biocompatibility Standard
ISO 10993-1:2018 establishes a risk-based evaluation framework organized around the nature and duration of body contact. The standard recognizes three contact categories with escalating test burdens:
| Contact Category | Duration Subclass | Key Endpoints Required | Example Devices |
|---|---|---|---|
| Surface-contacting (skin/mucosa) | Limited / Prolonged / Permanent | Cytotoxicity, sensitization, irritation | Tourniquets, compression bandages |
| Externally communicating (indirect blood path) | Limited / Prolonged / Permanent | + Systemic toxicity, genotoxicity, hemocompatibility | IV infusion lines, dialyzers, cardiopulmonary bypass tubing |
| Implant devices (tissue/bone/blood) | Limited / Prolonged / Permanent | + Implantation effects, chronic toxicity, carcinogenicity | Pacemaker seals, joint prostheses, vascular grafts |
The test selection is not a menu to pick from -- it is a decision tree. A material tested only for cytotoxicity and irritation may be adequate for a skin-contacting, limited-duration device (e.g., an examination glove). The same material proposed for a chronic indwelling catheter requires the full implant-device battery. The contact category, not the material, drives the testing requirement.
ISO 10993-5 (in vitro cytotoxicity) deserves special mention. It is required for every device regardless of contact category. The test uses L929 mouse fibroblast cells exposed to material extracts; a grade of 0 or 1 (non-cytotoxic or mildly cytotoxic) is generally required. This is the first, cheapest, and most commonly failed biocompatibility test -- any cytotoxic extractant detected here aborts the full evaluation until the material formulation is corrected.
Three Core Medical Elastomers
Silicone Rubber: The Biocompatibility Gold Standard
Silicone's dominance in implant-grade applications stems from a fundamental chemical property: the siloxane backbone (Si-O-Si) is inherently biocompatible, chemically inert, and resistant to oxidative degradation in ways that carbon-backbone polymers cannot match. The Si-O bond energy (~444 kJ/mol) exceeds the C-C bond (~348 kJ/mol), providing thermal and oxidative stability that translates directly to long-term in vivo performance.
Medical-grade silicone is not a single material but a family of formulations, distinguished by their curing chemistry and processing method:
| Grade | Cure System | Processing Method | Primary Applications | Key Quality Requirement |
|---|---|---|---|---|
| Heat-Cured (HTV) | Peroxide-initiated | Compression/transfer molding | Long-term implants, chronic indwelling catheters | Volatile content ≤ 0.5% (200°C × 4 h) |
| Liquid Silicone Rubber (LSR) | Addition-cure (Pt catalyst) | Injection molding | High-precision seals, valves, diaphragms | Zero peroxide decomposition byproducts |
| Room-Temp Vulcanizing (RTV) | Condensation or addition | Adhesive/sealant application | Bonding, potting, temporary device assembly | Addition-cure preferred (no acetic acid/amine evolution) |
| Fluorosilicone (FVMQ) | Peroxide | Compression molding | Implants requiring fuel/oil resistance | Trifluoropropyl substitution on backbone for chemical resistance |
Key Quality Metrics for Implant-Grade Silicone:
The difference between industrial silicone and medical-grade silicone is processing discipline, not base polymer chemistry. Critical quality indicators include:
- • Low molecular weight (LMW) siloxane residues: ≤ 0.5 wt% total. Cyclic siloxanes (D4, D5, D6) are under increasing regulatory scrutiny by EU REACH and are suspected endocrine disruptors. Medical grades undergo post-cure devolatilization (typically 200°C for 4+ hours in forced-air ovens) to drive off these species.
- • Heavy metal content: ≤ 5 mg/kg total. Platinum catalyst residues from LSR systems must be verified after curing; residual Pt above 10 ppm can cause cytotoxicity failures.
- • Cytotoxicity Grade: 0 (non-cytotoxic) per ISO 10993-5. This is non-negotiable for any implantable silicone.
- • Pyrogen/endotoxin limits: ≤ 0.5 EU/mL for devices contacting the cardiovascular system (USP <161>).
Principal Medical Applications of Silicone:
Silicone appears in medical devices spanning the full contact spectrum. Long-term implantable catheters (ventriculoperitoneal shunts, peritoneal dialysis catheters) exploit silicone's low thrombogenicity and resistance to encrustation. Implantable pulse generator (pacemaker/ICD) connector seals rely on silicone's compression set resistance over decades. Breast implant shells use crosslinked silicone elastomer for its tissue compatibility and fatigue resistance. Respiratory masks and anesthesia circuit tubing use silicone for its flexibility at body temperature and resistance to disinfectant chemicals.
Butyl Rubber (IIR/BIIR/CIIR): The Pharmaceutical Packaging Standard
Isobutylene-isoprene rubber (IIR) and its halogenated derivatives -- bromobutyl (BIIR) and chlorobutyl (CIIR) -- dominate pharmaceutical closure applications for one overriding reason: gas impermeability. The tightly packed, sterically hindered polyisobutylene backbone provides the lowest oxygen and moisture transmission rates of any commercial elastomer:
| Closure Material | O₂ Permeability (cm³·mm/m²·day·atm) | Moisture Vapor Transmission | Puncture Fragmentation | Typical Application |
|---|---|---|---|---|
| Conventional IIR | 100-200 | Low | Moderate (film lamination recommended) | Antibiotic vials, large-volume parenterals |
| Bromobutyl (BIIR) | 80-150 | Very low | Low (film often unnecessary) | Lyophilized injectable powders, sterile powders |
| Chlorobutyl (CIIR) | 80-150 | Very low | Low | Freeze-dried formulations |
| Film-laminated butyl (PTFE/ETFE face) | < 10 (barrier-limited) | Negligible | Near-zero | High-value biologics, monoclonal antibodies, mRNA formulations |
The choice between BIIR and CIIR for pharmaceutical stoppers is not trivial. BIIR provides faster cure rates and better adhesion to film laminates due to the higher reactivity of the allylic bromine. CIIR offers marginally better heat aging resistance. For lyophilized (freeze-dried) drug products, CIIR has historically been preferred because its slightly lower moisture regain (< 0.3 wt%) helps maintain the low residual moisture specification critical for lyophilized cake stability.
The key functional requirements for pharmaceutical closures are codified in USP <381> (Elastomeric Closures for Injections) and ISO 8871. These standards specify limits for:
- • Penetrability: Force required to insert a hypodermic needle through the stopper
- • Fragmentation: Number of visible rubber particles shed into solution after repeated needle puncture (critical for multi-dose vials)
- • Self-sealing: Ability of the puncture hole to reseal after needle withdrawal, preventing microbial ingress
- • Extractables profile: Organic and inorganic substances leached from the closure into the drug product over shelf life
For high-value biologics -- monoclonal antibodies, antibody-drug conjugates, cell and gene therapies -- film lamination with ETFE (ethylene tetrafluoroethylene) or PTFE provides a near-impermeable barrier that eliminates rubber-drug product contact entirely. This adds approximately $0.15-0.40 per stopper but is standard practice when the drug product value exceeds the closure cost by orders of magnitude.
Thermoplastic Polyurethane (TPU): The Catheter Workhorse
Thermoplastic polyurethane occupies a strategic middle ground: it offers the processability of a thermoplastic (extrusion, injection molding) with the elasticity of a thermoset rubber. Its hardness can be tuned from soft (70 Shore A, suitable for compliant balloon catheters) to rigid (75 Shore D, for structural hubs and connectors) by adjusting the hard-segment/soft-segment ratio -- a range unattainable with either silicone or butyl.
Three TPU chemistries are relevant to medical devices, differentiated by the soft segment:
| TPU Type | Soft Segment | Hardness Range | Key Strength | Key Weakness | Primary Use |
|---|---|---|---|---|---|
| Polyether TPU | PTMEG polyol | 70A-75D | Hydrolytic stability, flexibility, low-temperature performance | Oxidative degradation in vivo | Vascular catheters, endotracheal tubes, IV tubing |
| Polyester TPU | Adipate/butanediol polyester | 70A-75D | High tensile strength, abrasion resistance | Susceptible to hydrolysis at > 60°C | Short-term catheters, wound dressings |
| Polycarbonate TPU | Polycarbonate diol | 80A-75D | Best oxidative stability, best in vivo durability | Higher cost, some processing sensitivity | Chronic indwelling catheters, pacemaker lead insulation |
The critical limitation of TPU for long-term implant applications is its susceptibility to environmental stress cracking (ESC) and metal-ion-induced oxidation (MIO). When TPU is in contact with certain metals (particularly cobalt, chromium, and copper, which are common in pacemaker lead coils), the metal ions catalyze oxidative degradation of the polyether soft segment. This degradation manifests as surface pitting, cracking, and eventual loss of mechanical integrity. Polycarbonate TPU largely overcomes this vulnerability and is the material of choice for chronic implant leads where metallic conductor contact is unavoidable. However, for the most demanding implant applications (> 5 years), silicone remains the preferred alternative.
Sterilization Compatibility: The Hidden Design Constraint
Medical device sterilization is not a post-design afterthought -- it is a design input that should drive material selection from the start. Different sterilization modalities impose fundamentally different stresses on elastomers, and a material that performs perfectly in service may fail catastrophically during sterilization.
| Sterilization Method | Silicone | IIR/BIIR | TPU | EPDM | Notes |
|---|---|---|---|---|---|
| Steam autoclave 121°C (30 min) | Excellent | Good | Marginal | Excellent | TPU hydrolyzes with repeated cycles; limit to single-use devices |
| Steam autoclave 134°C (3 min) | Excellent | Fair | Poor | Very Good | IIR softens progressively above 121°C |
| Ethylene oxide (EtO) 55°C | Excellent | Very Good | Very Good | Excellent | Universal compatibility; residual EtO/ECH limits per ISO 10993-7 apply |
| Gamma irradiation 25-40 kGy | Good (yellowing possible) | Poor (chain scission) | Fair | Poor (chain scission) | IIR and EPDM degrade significantly; verify mechanicals post-irradiation |
| Gamma irradiation 40-50 kGy | Fair (crosslink density increase) | Poor (brittle failure) | Fair | Poor | Double-dose verification (2×25 kGy) may push silicone and TPU beyond acceptable limits |
| E-beam (electron beam) | Very Good | Fair | Good | Fair | Lower dose exposure per pass; multiple passes used for total dose |
| Hydrogen peroxide gas plasma (STERRAD) | Excellent | Very Good | Good | Very Good | Preferred for heat-sensitive devices; no aeration required |
Key Sterilization Design Rules:
- Gamma irradiation is a one-shot stressor. Unlike thermal aging (accumulated over time), the entire dose is delivered in minutes. IIR and EPDM are particularly susceptible because ionization events in the polymer backbone cause chain scission at the quaternary carbon atoms adjacent to the methyl side groups. BIIR retains properties slightly better than CIIR post-gamma due to the bromine atom's radical-trapping ability.
- EtO residual limits govern production scheduling. ISO 10993-7 specifies maximum allowable residues of ethylene oxide and ethylene chlorohydrin (ECH). Silicone absorbs significantly more EtO than other elastomers due to its high free volume. Dissipation to below the limit (typically < 1 µg/g EtO, < 50 µg/g ECH for limited-exposure devices) can require 7-14 days of forced aeration at elevated temperature. This aeration time must be built into production planning.
- Steam sterilization is the most aggressive test of a material's hydrolytic stability. The combination of heat and moisture attacks polyester TPU through ester bond hydrolysis and can extract unreacted monomers from any elastomer. Silicone's inorganic backbone provides inherent immunity to hydrolysis.
- Hydrogen peroxide gas plasma (STERRAD) has become the method of choice for heat-sensitive, moisture-sensitive devices. It operates at low temperature (45-55°C), leaves no toxic residues, and requires no aeration. The limitation is that the H₂O₂ plasma may oxidize certain unsaturated elastomers and cannot penetrate long, narrow lumens effectively.
Material Selection Decision Framework
The following decision tree summarizes the engineering trade-offs discussed above. Each branch represents a design constraint; follow it to the recommended material family, then select the specific grade based on sterilization compatibility and cost.
Medical Device Elastomer Requirement
│
├── Long-term implant (> 30 days tissue/blood contact)
│ ├── Needs oil/solvent resistance
│ │ └── Fluorosilicone (FVMQ), 50-70 Shore A
│ └── Standard implant environment
│ ├── Precision molding → LSR (addition-cure, injection molded)
│ └── Compression molding, high volume → HTV Silicone
│ └── Verify: USP Class VI + ISO 10993 full implant battery
│
├── Pharmaceutical closure (drug product contact)
│ ├── Standard small-molecule drug → BIIR or CIIR stopper
│ ├── Lyophilized (freeze-dried) product → CIIR (lower moisture)
│ ├── High-value biologic (mAb, gene therapy) → Film-laminated (ETFE/BIIR)
│ └── Verify: USP <381> penetrability + fragmentation + self-sealing
│
├── Single-use catheter / tubing (disposable, < 24 h contact)
│ ├── Cost-driven → Polyether TPU (extrusion-grade)
│ ├── Performance-driven → Silicone (clear, flexible, EtO-sterilized)
│ └── Verify: ISO 10993-5 cytotoxicity + 10993-10 irritation
│
├── Chronic indwelling catheter (7-30 days)
│ ├── Standard venous access → Polyether TPU
│ ├── High infection risk application → Silicone (lower biofilm adherence)
│ └── Verify: ISO 10993-5, -10, -11 + hemocompatibility (10993-4)
│
└── Extracorporeal circuit component (dialysis, bypass, apheresis)
├── Pump segment tubing → Silicone (fatigue life, hemocompatibility)
├── Connectors, housings → Polycarbonate TPU
└── Verify: Full hemocompatibility per ISO 10993-4Summary of Relevant Standards
| Standard | Scope | Key Requirement |
|---|---|---|
| USP <87> | Biological reactivity, in vitro | Agar diffusion / direct contact / elution test on L-929 cells |
| USP <88> | Biological reactivity, in vivo | Class I-VI: systemic injection, intracutaneous, implantation as required |
| USP <381> | Elastomeric closures for injections | Penetrability, fragmentation, self-sealing, physicochemical tests |
| ISO 10993-1:2018 | Biological evaluation -- general principles | Risk-based categorization by contact nature and duration |
| ISO 10993-5 | In vitro cytotoxicity | Extract dilution test; Grade 0-1 required for all devices |
| ISO 10993-4 | Hemocompatibility | Complement activation, hemolysis, thrombosis (for blood-contacting devices) |
| ISO 10993-7 | Ethylene oxide sterilization residuals | EtO < 1-10 µg/g (device-dependent); ECH limits per exposure category |
| ISO 10993-10 | Sensitization and irritation | Guinea pig maximization or LLNA; intracutaneous irritation |
| ISO 10993-11 | Systemic toxicity | Acute systemic injection test; subacute/subchronic per implantation duration |
| ISO 8871 | Elastomeric parts for parenterals | Fragmentation, self-sealing, extractables, identity testing |
| YY/T 0160-2014 | Chinese pharmacopoeia -- butyl closures | BIIR/CIIR physical and chemical specifications per NMPA requirements |
Medical-Grade Elastomer Supply & Technical Support
Nanjing Yuhang Rubber Co., Ltd. provides medical-grade elastomer components manufactured under strict quality controls.
Product Capabilities:
- • Silicone medical components: Seals, gaskets, diaphragms, and tubing in HTV and LSR grades; USP Class VI certified; ISO 10993-5 cytotoxicity Grade 0 verified
- • Pharmaceutical closures: IIR, BIIR, and CIIR stoppers per USP <381> and ISO 8871 specifications; film-laminated options available for biologics
- • Fluorosilicone seals: For implantable devices requiring chemical resistance
- • Cleanroom manufacturing: ISO Class 7 (Class 10,000) and Class 8 (Class 100,000) production environments
Quality Certifications:
- • ISO 9001:2015 certified quality management system
- • ISO 13485 medical device quality management (in progress)
- • USP Class VI material certification available on request
- • Sterilization validation support: steam, EtO, gamma, and e-beam compatibility data
Contact:
- • Website: www.yhrubbertech.com
- • Email: wudingming08@gmail.com
- • Phone: +86-25-58761609
*Explore: All Industry Application Articles | About the Company | Product Catalog*
FAQ
Can this article be used as the final selection basis?
It is intended for preliminary technical review. Final material or product selection should be confirmed with the actual medium, temperature, load, dimensions, drawings and sample testing when needed.
What information should be provided for an inquiry?
Please provide the application equipment, working medium, temperature range, dimensions, quantity, drawing or sample information so the technical discussion can be organized faster.